Valuation
- Market cap
- 887,000
- Revenue TTM
- $0
- Net income TTM
- $-9,420,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 859,700
- Avg volume
- 1,744,240
- Day's range
- $0.06 – $0.12
- Shares out
- 2,072,000
- Stochastic %K
- 15%
- Beta
- 0.16
- Analysts
- Sell
- Price target
- $8.25
Company profile
IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings,...
Show more
IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee.
- Industry
- Medical Care Facilities
- Sector
- Healthcare
- Phone
- 303 898 5896
- Website
- https://imacregeneration.gcs-web.com
- Address
- 3401 Mallory Lane, Suite 100, Franklin, United States
Latest news
No headlines yet.
